ArticleWorld journal of diabetes2024

Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis.

Xiao-Lan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.